✦ LIBER ✦

Adjusting for treatment changes in epilepsy: causal analysis of randomised controlled trial survival outcomes in the presence of departure from randomised treatment

✍ Scribed by Susanna Dodd,Paula Williamson,Ruwanthi Kolamunnage Dona,Marta Van der Hoek…

Book ID: 126377131
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 120 KB
Volume: 14
Category: Article
ISSN: 1468-6708
DOI: 10.1186/1745-6215-14-S1-O37

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A sensitivity analysis framework for the

A sensitivity analysis framework for the treatment effect measure used in the meta-analysis of comparative binary data from randomised controlled trials

✍ Dan Jackson; Rose Baker; Jack Bowden 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Risk of sudden unexpected death in epile

Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials

✍ Philippe Ryvlin; Michel Cucherat; Sylvain Rheims 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 134 KB

Antidepressants for the treatment of dep

Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials

✍ Price, A.; Rayner, L.; Okon-Rocha, E.; Evans, A.; Valsraj, K.; Higginson, I. J.; 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 413 KB

The TrimTots programme for prevention an

The TrimTots programme for prevention and treatment of obesity in preschool children: evidence from two randomised controlled trials

✍ Lanigan, Julie; Collins, Sarah; Birbara, Toni; Kokoreli, Maria; Singhal, Atul 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 59 KB

Prediction of successful outcome in a ra

Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C

✍ Vandelli, Carmen; Renzo, Francesco; Braun, Hans Bertram; Tisminetzky, Sergio; Al 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

To evaluate the efficacy of a 12-month course of recombinant interferon alpha (IFN-␣2b), and to assess predictive factors of successful response to IFN therapy in chronic active hepatitis C (HCV CAH), 242 patients with histologically proven HCV CAH were assigned randomly to two groups, one treated w

PCV6 ESTIMATING THE INCREMENTAL BENEFIT

PCV6 ESTIMATING THE INCREMENTAL BENEFIT ON FINAL OUTCOMES OF ROSUVASTATIN 40 MG OVER 20 MG IN THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLAEMIA BASED ON A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

✍ SL Kingslake; SJ Edwards 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB